Join us at the 7TH Annual Pathways to Access & Reimbursement, designed to bring clarity to some of the greatest challenges facing manufacturers, patients, and payers alike in this radically altered healthcare climate.
Interested in viewing the virtual conference from January 2021?
If you weren’t able to attend the 6th Annual Conference on Pathways to Access & Reimbursement, you can still purchase the recordings and catch-up on critical information on your own schedule. Access information delivered by our esteemed speakers as you would at an onsite event.
Learn MoreWHO ATTENDS
Practitioners at every level with experience in:
- Pricing
- Reimbursement
- Market access
- Patient access
- Government and regulatory affairs
- Health economics
- Research and development
- Policy and compliance
- Pharmacy services
- Marketing
- National trade
- Formularies
- Business development
- Sales
From brand generic and manufacturing companies involved in:
- Product development
- Public drug programs
- Pharmaceutical benefits
- Pharmaceutical strategy
- Drug submissions
- Formulary management
- Policy and economic analysis
- Provider services and
- relations
- Pharmacy
And representatives from:
- Associations
- Patient Advocacy Groups
The complete agenda will be released shortly.
Watch for the announcement in your inbox by signing up to the mailing list today.
Testimonials
Great overview, gave me a different perspective. Got me thinking differently.
I liked the quality of the speakers.
Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.
Past Attending Organizations Include
- Sidley & Austin LLP
- Paladin Labs Inc
- Boehringer Ingelheim Canada Ltd
- Clinical Trials Ontario
- Sun Life Financial
- Green Shield Canada
- PIVINA Consulting Inc
- LifeLabs
- Amgen Canada Inc
- Pan-Canadian Pharmaceutical Alliance
- Canopy Growth Corporation
- Otsuka Canada Pharmaceutical Inc
- Norton Rose Fulbright Canada LLP
- GSK
- PMPRB
- Cancer Care Ontario
- Bristol Myers Squibb
- Cornerstone Research Group
- CADTH
- Novartis Canada
- Sandoz Canada Inc
- Innovative Medicines Canada
- Ipsen Biopharmaceuticals Canada
- Equitable Life of Canada
- SteriMax
- Brougham Consulting Inc
- Osler Hoskin & Harcourt LLP
- Canadian Organization for Rare Disorders
- Leslie Dan Faculty of Pharmacy
- GlaxoSmithKline Plc
- RWW Consultants
- PENDOPHARM
- AstraZeneca Canada Inc
- Innomar Strategies Inc
- AbbVie Corporation
- INESSS
- Great West Life
- Jamp Pharma Corporation
